Switching to Doravirine/Islatravir (100 mg/0.25 mg) Once Daily Maintains Viral Suppression Through Week 48 in the Presence of Archived NNRTI Resistance-Associated Mutations and/or M184I/V in Proviral DNA

Conference Reports for NATAP

ID Week 2025
October 19-22
Atlanta, GA


Switching to Doravirine/Islatravir (100 mg/0.25 mg) Once Daily Maintains Viral Suppression Through Week 48 in the Presence of Archived NNRTI Resistance-Associated Mutations and/or M184I/V in Proviral DNA

	Download the PDF here IDWeek; Atlanta, GA, USA; Oct. 19-22, 2025